| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |